One year of Lamivudine therapy for portuguese patients with chronic hepatitis B.
OBJECTIVE: To further verify the efficacy and safety of locally manufactured lamivudine on patients with chronic hepatitis B (CHB). METHODS: 2200 patients with CHB were recruited and received lamivudine orally 100 mg once daily for 12 months. The efficacy assessments included virologic response rate...
Autor principal: | |
---|---|
Outros Autores: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
Formato: | article |
Idioma: | eng |
Publicado em: |
2012
|
Assuntos: | |
Texto completo: | http://hdl.handle.net/10400.10/827 |
País: | Portugal |
Oai: | oai:repositorio.hff.min-saude.pt:10400.10/827 |